Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6

Area of Science:

• Virology
• Immunology
• Diagnostic Assays

Background:

• Conventional serological grouping methods for hepatitis C virus (HCV) are limited to specific genotypes (1a, 1b, 2a, 2b).
• Accurate HCV genotyping is crucial for effective treatment and management.
• There is a need for reliable serotyping assays that cover a broader range of HCV genotypes.

Purpose of the Study:

• To evaluate the performance of the Murex HCV serotyping 1 to 6 assay for serologically grouping various HCV genotypes.
• To determine the sensitivity, specificity, and concordance of the Murex assay across different HCV genotypes (1a, 1b, 2a, 2b, 3a, 3b).

Main Methods:

• The study utilized the Murex HCV serotyping 1 to 6 assay, an enzyme-linked immunosorbent assay (ELISA).
• The assay employs genotype-specific peptides from the NS4 region of the hepatitis C virus.
• 365 patients infected with HCV genotypes 1a, 1b, 2a, 2b, 3a, or 3b were included in the study.

Main Results:

• The Murex assay demonstrated high overall sensitivity (78.4%) and specificity (98.6%).
• Sensitivity varied by genotype, ranging from 50.0% (3a) to 100% (1a).
• Overall concordance was 77.5%, with genotype-specific concordance rates also reported.

Conclusions:

• The Murex HCV serotyping 1 to 6 assay is a valuable tool for identifying hepatitis C virus genotypes, particularly when conventional methods are insufficient.
• This assay can aid in serotyping when genotypes other than 1a, 1b, 2a, or 2b are suspected or when results from other assays are indeterminate.
• The assay's performance suggests its utility in diverse ethnic groups and clinical settings requiring broader HCV genotype identification.